Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P254: The significance of LCI Index of rectal mucosa of the patients of ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

K. Uchiyama1*, T. Takagi1, S. Kashiwagi1, Y. Toyokawa1, N. Yagi2, Y. Naito1, Y. Itoh1

1Kyoto Prefectural University of Medicine, Molecular Gastroenterology and Hepatology, Kyoto, Japan, 2Murakami Memorial Hospital, Asahi University, Department of Gastroenterology, Gifu, Japan

P255: Limitations of a community calprotectin service and outcomes from patients tested outside of an approved pathwayECCO '18 Vienna
Year: 2018
Authors:

L. James1, R. Gama1, C. Ford1, B. McKaig2, S. Whitehead1, S. Pelitari2, H. Steed2, M. Brookes2*

1The Royal Wolverhampton NHS Trust, Department of Clinical Chemistry, Wolverhampton, UK, 2The Royal Wolverhampton NHS Trust, Department of Gastroenterology, Wolverhampton, UK

P256: Risk of relapse according to endoscopic score of mucosal healing (mayo score 0 vs. 1): Clinical evaluation is still necessaryECCO '18 Vienna
Year: 2018
Authors:

L. Ramos1*, R. De La Barreda1, M. Carrillo-Palau1, I. Alonso-Abreu1, N. Hernández-Álvarez1, G. Hernández1, A. Hernandez Camba1, L. Martínez-Blanco2, A. Jiménez3, E. Quintero Carrión1,4

1Hospital Universitario de Canarias, Gastroenterology, La Laguna, Spain, 2Hospital Universitario de Canarias, Pathology, La Laguna, Spain, 3Hospital Universitario de Canarias, Research Unit, La Laguna, Spain, 4Universidad de La Laguna, La Laguna, Spain

P257: Surgical and hospital admission in adults newly diagnosed with inflammatory bowel disease (IBD) in the biological era in Spain: Results of the nationwide EpidemIBD study of GETECCUECCO '18 Vienna
Year: 2018
Authors:

M. Chaparro1,2,3,4*, J.L. Cabriada5, M.J. Casanova1,2,4, D. Ceballos6, M. Esteve4,7, H. Fernández8, M. Barreiro-de Acosta9, V. García-Sánchez10,11, D. Ginard12, F. Gomollón4,13,14, R. Llorente Poyatos15, P. Nos4,16, S. Riestra17, M. Rivero18, P. Robledo19, C. Rodríguez Gutiérrez20, B. Sicilia21, E. Torrella22, E. García Esquinas23,24,25, J.P. Gisbert1,2,3,4, on behalf of the EpidemIBD group

1Hospital Universitario de La Princesa, Gastroenterology Unit, Madrid, Spain, 2Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain, 3Universidad Autónoma de Madrid, Madrid, Spain, 4Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain, 5Hospital de Galdakao-Usansolo, Gastroenterology Unit, Vizcaya, Spain, 6Hospital Universitario de Gran Canaria Doctor Negrín, Gastroenterology Unit, Las Palmas de Gran Canaria, Spain, 7Consorci Sanitari Terrassa, Gastroenterology Unit, Tarrasa, Spain, 8Hospital San Pedro, Gastroenterology Unit, Logroño, Spain, 9Hospital Clínico Universitario de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain, 10Hospital Universitario Reina Sofía, Gastroenterology Unit, Córdoba, Spain, 11IMIBIC, Córdoba, Spain, 12Hospital Universitario Son Espases, Gastroenterology Unit, Palma de Mallorca, Spain, 13Hospital Clínico Universitario Lozano Blesa, Gastroenterology Unit, Zaragoza, Spain, 14ISS Aragón, Zaragoza, Spain, 15Hospital General Universitario de Ciudad Real, Gastroenterology Unit, Ciudad Real, Spain, 16Hospital Universitario y Politécnico de La Fe, Gastroenterology Unit, Valencia, Spain, 17Hospital Universitario Central de Asturias, Gastroenterology Unit, Oviedo, Spain, 18Hospital Universitario de Marqués de Valdecilla, Gastroenterology Unit, Santander, Spain, 19Hospital San Pedro de Alcántara, Gastroenterology Unit, Cáceres, Spain, 20Complejo Hospitalario de Navarra, Gastroenterology Unit, Pamplona, Spain, 21Hospital Universitario de Burgos, Gastroenterology Unit, Burgos, Spain, 22Hospital General Universitario Morales Meseguer, Gastroenterology Unit, Murcia, Spain, 23Universidad Autónoma de Madrid, Preventive Medicine and Public Health, Madrid, Spain, 24IdiPAZ, Madrid, Spain, 25Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain

P258: 3D printed models in fistulising perianal Crohn's as a clinical tool boost education with patients and traineesECCO '18 Vienna
Year: 2018
Authors:

K. Sahnan1*, S.O. Adegbola1, P.J. Tozer1, A. Gupta2, J. Warusavitarne1, O.D. Faiz1, A.L. Hart3, R.K. Phillips1, P.F. Lung2

1St Mark's Hospital, Colorectal Surgery, London, UK, 2St Mark's Hospital, Gastrointestinal Imaging, London, UK, 3St Mark's Hospital, IBD/Physiology, London, UK

P259: Measures of predicting inflammatory and fibrotic strictures in Crohn’s disease patients using magnetic resonanceECCO '18 Vienna
Year: 2018
Authors:

R. Stack1*, C. O'Brien2, T. Nuzum3, L. Kumar3, P. Maheshwari3, N. Breslin4,5, B. Ryan4,5, A. O'Connor3, I. Murphy6, D. Mc Namara4,5

1Tallaght Hospital, Gastroenterology, Dublin 24, Ireland, 2Talllaght Hospital, Dublin, Ireland, 3Talllaght Hospital, Gastroenterology, Dublin, Ireland, 4Adelaide and Meath Hospital, Dublin, Incorporating The National Children's Hospital, Department of Gastroenterology, Dublin, Ireland, 5Trinity College Dublin, Dublin, Ireland, 6Adelaide and Meath Hospital, Dublin, Incorporating The National Children's Hospital, Department of Radiology, Dublin, Ireland

P260: Point of Care Ultrasound (POCUS) when performed by gastroenterologists with 200 supervised scans is accurate and clinically useful for patients with Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

I. Wang1, M. Kamm1,2, D. Wong1,2, S. Bell1,2, W. Connell1, A. Thompson1,2, K. Novak3, E. Wright1*

1St Vincent's Hospital, Department of Gastroenterology, Melbourne, Australia, 2The University of Melbourne, Parkville, Australia, 3University of Calgary, Department of Gastroenterology, Calgary, Canada

P261: Asking about bowel control problems in IBD: Results of face-to-face screening vs. self-reportingECCO '18 Vienna
Year: 2018
Authors:

C. Norton1*, A. Hart2, J. Duncan3, A. Emmanuel4, C. Knowles5, S. Kerry6, D. Lanz6, V. Berdunov6, V. Madurasinghe6, H. Terry7, A. Verjee8, L. Dibley9,10

1King's College London, Florence Nightingale School of Nursing and Midwifery, London, UK, 2St Mark's Hospital, Harrow, London, UK, 3Guy's and St Thomas' NHS Foundation Trust, Department of Gastroenterology, London, UK, 4University College Hospital, Gi Division, London, UK, 5Queen Mary University London, London, UK, 6Queen Mary University London, Pragmatic Clinical Trials Unit, London, UK, 7Crohn's and Colitis UK, Department of Policy, Public Affairs, and Research, St Albans, UK, 8Patient representative, London, UK, 9University of Greenwich, Faculty of Education and Health, London, UK, 10Bart's Health NHS Trust, Academic Research Centre, London, UK

P262: New faecal calprotectin cut-off points for remission and active disease defined by UCEIS and Nancy indices in ulcerative colitis (UC)ECCO '18 Vienna
Year: 2018
Authors:

A. Walsh1*, A. Kormilitzin2, C. Hinds3, V. Sexton4, S. Bond3, J. Wilson1, O. Brain1, S. Keshav1, H. Uhlig1, J. Geddes4, G. Goodwin4, M. Peters5, G. Collins6, S. Travis1

1John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, UK, 2Mathematical Institute, Oxford, UK, 3Big Data Institute, Oxford, UK, 4University of Oxford, Psychiatry Department, Oxford, UK, 5University of Oxford, Nuffield Department of Population Health, Oxford, UK, 6University of Oxford, Centre for Statistics in Medicine, Oxford, UK

P263: Evaluation of fatigue in inflammatory bowel disease: a useful tool in daily practiceECCO '18 Vienna
Year: 2018
Authors:

S. Saraiva*, J. Cortez-Pinto, R. Barosa, J. Castela, I. Rosa, J. Pereira da Silva, A. Dias Pereira

Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisboa, Portugal

P264: Investigation of inconsistent score patients by using Lewis Score and CECDAI in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

T. Omori*, S. Hosoya, K. Yasuhiro, H. Kambayashi, S. Murasugi, A. Ito, M. Yonezawa, S. Nakamura, K. Tokushige

Tokyo Women's Medical University, Institute of Gastroenterology, Tokyo, Japan

P265: Platelet activation by activated von Willebrand factor is a marker of intestinal wound healing in patients with Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

T. Manon-Jensen1*, L. Langholm1, S. Sun1, J.H. Mortensen1, Y. He1, A. Krag2, M.D. Jensen3, A.-C. Bay-Jensen1, J. Kjeldsen2, M.A. Karsdal1

1Nordic Bioscience, Biomarker and Research, Herlev, Denmark, 2Odense University Hospital, Kerteminde, Denmark, 3Lillebaelt Hospital Vejle, Internal Medicine, Section of Gastroenterology, Vejle, Denmark

P266: First step towards validation of the Quality of Working Life Questionnaire (QWLQ) in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

S. van Gennep1*, A.G. de Boer2, K.G. Gecse1, C.I. Ponsioen1, J.K. Sluiter2, G.R. D'Haens1, M. Löwenberg1

1Academic Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 2Academic Medical Center, Coronel Institute of Occupational Health, Amsterdam, The Netherlands

P267: Long-term outcome of anti-TNF therapy in children with Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

J.H. Park1*, Y.J. Lee1,2, S.W. Mun1

1Pusan National University, Pediatrics, Yansan, South Korea, 2Pusan National University Yangsan Hospital, Pediatrics, Yangsan, South Korea

P268: Ocular manifestations in a tertiary IBD centre: Better to keep an eye onECCO '18 Vienna
Year: 2018
Authors:

G. Rizzatti1*, S. Gerardi1, C. Manganelli2, V. Petito1, C. Graziani1, G. Holleran1, L.R. Lopetuso1, E. Schiavoni1, D. Napolitano1, M. Pizzoferrato3, L. Laterza1, G. Ianiro1, A. Caporossi2, A. Papa4, A. Armuzzi4, A. Gasbarrini1, F. Scaldaferri1

1A. Gemelli University Policlinic Foundation - Catholic University of Sacred Heart, Gastroenterological Area, Gastroenterological and Endocrino-Metabolical Sciences Department, Rome, Italy, 2A. Gemelli University Policlinic Foundation - Catholic University of Sacred Heart, Head and Neck Department-Ophthalmology Division, Rome, Italy, 3A. Gemelli University Policlinic Foundation - Catholic University of Sacred Heart, Hospital Nutrition Team, Rome, Italy, 4A. Gemelli University Policlinic Foundation - Catholic University of Sacred Heart, IBD Unit, Presidio Columbus, Rome, Italy

P269: A new dedicated capsule for diagnosis and monitoring of Crohn’s disease. First patient seriesECCO '18 Vienna
Year: 2018
Authors:

C. Calabrese1*, A. Calafiore1, P. Gionchetti1, G.E. Tontini2, F. Rizzello1, M. Vecchi3, M. Campieri1

1University of Bologna, Dept of Clinical and Surgical Sciences - IBD Unit, Bologna, Italy, 2IRCCS Policlinico San Donato, Milan, Italy, 3University of Milan, Milan, Italy

P270: Bile acid malabsorption incidence and diagnosis in clinical practiceECCO '18 Vienna
Year: 2018
Authors:

B. Gros1*, L. Mena2,3, J.M. Benítez1,3, E. Carmona2, S. Marín1,3, F. Maza2, R. Medina3, V. García-Sánchez1,3, E. Iglesias-Flores1,3

1Reina Sofia University Hospital, Gastroenterology, Córdoba, Spain, 2Reina Sofia University Hospital, Nuclear Medicine, Córdoba, Spain, 3Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, Spain

P271: Predictive factors of a clinical severe course of Crohn’s disease: A monocentric studyECCO '18 Vienna
Year: 2018
Authors:

K. Agar*, L. Hamzaoui, S. Jardak, M. Medhioub, A. Khsiba, M.M. Azzouz

Med Taher Maamouri Hospital, GastroEnterology department, Nabeul, Tunisia

P272: Predictors of health-related quality of life in patients with newly diagnosed moderate to severe ulcerative colitis: Results from the MOSAIC cohort in KoreaECCO '18 Vienna
Year: 2018
Authors:

Y.M. Park1*, C.K. Lee1, S.N. Hong2, J.P. Im3, B.D. Ye4, J.M. Cha1, J.M. Cha1, S.-A. Jung5, K.-M. Lee6, D.I. Park7, Y.T. Jeen8, Y.S. Park9, J.H. Cheon10, H.-S. Kim11, Y. Kim11, H.J. Kim1

1Kyung Hee University, School of Medicine, Seoul, South Korea, 2Sungkyunkwan University, School of Medicine, Seoul, South Korea, 3Seoul National University, College of Medicine, Seoul, South Korea, 4University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 5Ewha Womans University, School of Medicine, Seoul, South Korea, 6St. Vincent's Hospital, The Catholic University, Seoul, South Korea, 7Kangbuk Samsung Hospital Sungkyunkwan University, Department of Internal Medicine, Seoul, South Korea, 8Korea University, College of Medicine, Seoul, South Korea, 9Eulji University, College of Medicine, Seoul, South Korea, 10Yonsei University, College of Medicine, Seoul, South Korea, 11Janssen Korea, Medical affairs, Seoul, South Korea

P273: Efficacy and safety of upadacitinib maintenance treatment for moderate to severe Crohn’s disease: Results from the CELEST studyECCO '18 Vienna
Year: 2018
Authors:

J. Panes1*, W.J. Sandborn2, E.V. Loftus Jr.3, G. Van Assche4, S. Ghosh5, Q. Zhou6, S. Goteti6, J.V. Enejosa6, A.L. Pangan6, A.P. Lacerda6

1Hospital Clínic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain, 2University of California San Diego, La Jolla, USA, 3Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, USA, 4University Hospitals Leuven, Leuven, Belgium, 5University of Birmingham, Birmingham, UK, 6AbbVie Inc., North Chicago, USA